Company Profiles

driven by the PitchBook Platform

Destiny Pharma

Description

Provider of antimicrobial drugs designed to improve outcomes for patients and the delivery of medical care. The company's anti-microbial drug platform, the XF Drugs Series, act via an ultra-rapid action which kill bacteria, enabling healthcare providers to prevent post surgical infections.

1996

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$4.68M

Latest Deal Amount

$11.8M

Total Amount Raised

Description

Provider of antimicrobial drugs designed to improve outcomes for patients and the delivery of medical care. The company's anti-microbial drug platform, the XF Drugs Series, act via an ultra-rapid action which kill bacteria, enabling healthcare providers to prevent post surgical infections.

Website:

www.destinypharma.com

Formerly Known As

Destiny Consultants

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Sussex Innovation Centre, Science Park Square Falmer Brighton BN1 9SBEngland +44 (0)12 7370 4440
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Destiny Pharma's full profile, request a free trial.

Destiny Pharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Destiny Pharma Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Angel CoFundAngel GroupMinority000 0000000 0000
HSBC Mutual Fund IndiaOtherMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Juno CapitalAsset ManagerMinority000 0000000 0000
Longbow CapitalVenture CapitalMinority000 0000000 0000
Angel CoFund Angel Group
HSBC Mutual Fund India Other
Individual Investor Angel (individual)
Juno Capital Asset Manager
Longbow Capital Venture Capital

Destiny Pharma Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Neil ClarkChief Executive Officer & Board Member
Simon SacerdotiBoard Member & Chief Financial Officer
William Love Ph.DFounder, Chief Scientific Officer & Board Member
David ScottBoard Member & Commercial Director
Ian HayterDirector, Project
Neil Clark Chief Executive Officer & Board Member
Simon Sacerdoti Board Member & Chief Financial Officer
William Love Ph.D Founder, Chief Scientific Officer & Board Member
David Scott Board Member & Commercial Director
Ian Hayter Director, Project

Destiny Pharma Board Members (11)

NameRepresentingRoleSinceContact
Info
Anja König Ph.DNovartis Venture FundManaging Director000 0000
Anthony EagleDestiny PharmaBoard Member000 0000
David RoblinSelfBoard Member & Medical Director000 0000
David ScottDestiny PharmaBoard Member & Commercial Director000 0000
Geoffrey Howard MatthewsSelfBoard Member000 0000
Anja König Ph.D Managing Director Novartis Venture Fund
Anthony Eagle Board Member Destiny Pharma
David Roblin Board Member & Medical Director Self
David Scott Board Member & Commercial Director Destiny Pharma
Geoffrey Howard Matthews Board Member Self
Request full access to PitchBook